The health‐related quality of life effects of once‐daily cetirizine HCl in patients with seasonal allergic rhinitis: a randomized double‐blind, placebo‐controlled trial
Authors:
- 5 March 2003
- journal article
- clinical trial
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 33 (3) , 351-358
Abstract
Summary: Background Seasonal allergic rhinitis (SAR) is characterized by subjectively irritating symptoms that can have a substantial impact on the patient's health‐related quality of life (HRQL), adversely affecting physical and social or work activity, interpersonal relationships, and general psychological well‐being. The objective of this study was to test the effect of cetirizine HCl 10 mg once daily on the HRQL of adult patients 18–65 years of age with SAR, concurrently assessing safety and efficacy.Methods Randomized double‐blind, placebo‐controlled, parallel group trial conducted during the 1999 spring SAR season at 19 centers in the US. Following a 1‐week placebo run‐in period, qualified patients were randomized to cetirizine 10 mg, or placebo once daily for a 2‐week treatment period. Change in Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) and Total Symptom Severity Complex (TSSC) scores from baseline were the primary outcomes of interest.Results Of the 611 patients enrolled, 403 (66%) were randomized. Cetirizine‐treated patients reported significantly greater improvement in overall HRQL (P < 0.001) and in each of the seven domains of the RQLQ at all time‐points (P < 0.05 to < 0.001) than the placebo group. They also experienced significantly greater symptom relief (P < 0.001) and were more satisfied with treatment (65% vs. 44%) compared to the placebo group. Correlations between symptomatic relief and overall HRQL improvement were moderate to strong and statistically significant (r = 0.49–0.68, P < 0.01).Conclusions Results of this study are consistent with previous investigations, suggesting cetirizine HCl 10 mg taken once daily in the morning offers symptomatic relief that improves the HRQL of adults suffering from SAR.Keywords
This publication has 31 references indexed in Scilit:
- Treatment of chronic rhinitis by an allergy specialist improves quality of life outcomesAnnals of Allergy, Asthma & Immunology, 1999
- Impact of cetirizine on the burden of allergic rhinitisAnnals of Allergy, Asthma & Immunology, 1999
- Quality of life in allergic rhinitisAnnals of Allergy, Asthma & Immunology, 1999
- Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitisAnnals of Allergy, Asthma & Immunology, 1999
- Impact on quality of life during an allergen challenge research trialAnnals of Allergy, Asthma & Immunology, 1999
- Demonstration of therapeutic equivalence of generic and innovator beclomethasone in seasonal allergic rhinitisAnnals of Allergy, Asthma & Immunology, 1999
- Executive Summary of Joint Task Force Practice Parameters on Diagnosis and Management of RhinitisAnnals of Allergy, Asthma & Immunology, 1998
- Comparison of Efficacy and Safety of Cetirizine and Ebastine in Patients with Perennial Allergic RhinitisAnnals of Allergy, Asthma & Immunology, 1998
- Onset of Action and Efficacy of Terfenadine, Astemizole, Cetirizine, and Loratadine for the Relief of Symptoms of Allergic RhinitisAnnals of Allergy, Asthma & Immunology, 1997
- Comparative Study of Cetirizine and Terfenadine Versus Placebo in the Symptomatic Management of Seasonal Allergic RhinitisAnnals of Allergy, Asthma & Immunology, 1996